https://pharmaceutical-journal.com/article/feature
Post# of 653
Aviptadil
Synthetic form of human vasoactive intestinal peptide;
Indicated for treatment of erectile dysfunction;
Reduces inflammation in the lungs and protects the alveolar type II cells that are believed to be an entry route for the SARS-CoV-2 to invade the lungs.
Ongoing trials
ACTIV-3b;
An Adaptive Platform Trial for Critically Ill Patients (I-SPY_COVID);
‘Inhaled Aviptadil for the Treatment of Non-Acute Lung Injury in COVID-19’ (AVINALI).